Skip to main content

Table 1 Summary of research objectives

From: Protocol of a monocentric, double-blind, randomized, superiority, controlled trial evaluating the effect of in-prison OROS-methylphenidate vs. placebo treatment in detained people with attention-deficit hyperactivity disorder (BATIR)

Topic

Outcome

In prison (3 months)

Post-release (12 months)

Clinical

Severity of ADHD core symptoms

Primary objective (O1)

-

Medication adherence

Secondary objective (O4)

Behavioral

Acute events

Secondary objective (O2)

-

Study retention

Secondary objective (O5)

Recidivism

Risk of recidivism

Secondary objective (O3)

-

One-year recidivism

-

Secondary objective (O7)

Side effects

Side effects

Secondary objective (O8)

-

Economical

Cost-benefits

Secondary objective (O6)